Paul Hudson, Sanofi CEO (via Getty)
Sanofi partners up with dominant ADC player Seagen, doubling down on oncology in hunt for a better pipeline
Nearly 20 years after its first foray into ADCs, Sanofi has come back to double down on the field with a new alliance forged with …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
